Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Fox

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2010
1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitorsMichael B Tollefson, Brad A Acker, E J Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Acidic triazoles as soluble guanylate cyclase stimulatorsLee R Roberts, Paul A Bradley, Mark E Bunnage, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of a highly potent series of TLR7 agonistsPeter Jones, David C Pryde, Thien-Duc Tran, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infectionThien-Duc Tran, David C Pryde, Peter Jones, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2010
1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitorsMichael B Tollefson, Brad A Acker, E J Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitorsMelanie S Glossop, Richard J Bazin, Kevin N Dack, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Acidic triazoles as soluble guanylate cyclase stimulatorsLee R Roberts, Paul A Bradley, Mark E Bunnage, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2011
Discovery of a highly potent series of TLR7 agonistsPeter Jones, David C Pryde, Thien-Duc Tran, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infectionThien-Duc Tran, David C Pryde, Peter Jones, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitorsDafydd R Owen, John K Walker, E Jon Jacobsen, et al.
Pageof 9